A Predictive Model for Clinical Asthma Exacerbations Using Albuterol eMDPI (ProAir Digihaler): A 12-Week, Open-Label Study

被引：0
|
作者：
Safioti, G. [1 ]
Granovsky, L. [2 ]
Li, T. [3 ]
Reich, M. [2 ]
Cohen, S. [4 ]
Hadar, Y. [4 ]
Pleasants, R. [5 ]
Hill, T. [3 ]
DePietro, M. [3 ]
机构：
[1] Teva Pharmaceut, Amsterdam, Netherlands
[2] Teva Pharmaceut Ltd, Petah Tiqwa, Israel
[3] Teva Branded Pharmaceut R&D Inc, Malvern, PA USA
[4] Yellow Rd, Petah Tiqwa, Israel
[5] Univ N Carolina, Sch Med, Div Pulm Med & Crit Care, Chapel Hill, NC 27515 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2019年 / 199卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A7307
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Low versus high carbohydrate diet in type 1 diabetes: A 12-week randomized open-label crossover study
    Schmidt, Signe
    Christensen, Merete B.
    Serifovski, Nermin
    Damm-Frydenberg, Camilla
    Jensen, Jens-Erik B.
    Floyel, Tina
    Storling, Joachim
    Ranjan, Ajenthen
    Norgaard, Kirsten
    DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1680 - 1688
  • [42] Aripiprazole for Irritability in Asian Children and Adolescents with Autistic Disorder: A 12-Week, Multinational, Multicenter, Prospective Open-Label Study
    Kim, Hyo-Won
    Park, Eun-Jin
    Kim, Ji-Hoon
    Boon-Yasidhi, Vitharon
    Tarugsa, Jariya
    Reyes, Alexis
    Manalo, Stella
    Joung, Yoo-Sook
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2018, 28 (06) : 402 - 408
  • [43] Reboxetine Adjuvant Therapy in Patients With Schizophrenia Showing a Suboptimal Response to Clozapine A 12-Week, Open-Label, Pilot Study
    Bruno, Antonio
    Zoccali, Rocco
    Bellinghieri, Paolo Micali
    Pandolfo, Gianluca
    De Fazio, Pasquale
    Spina, Edoardo
    Muscatello, Maria Rosaria A.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (05) : 620 - 623
  • [44] Effects of Ezetimibe on Glucose Metabolism in Patients With Type 2 Diabetes: A 12-Week, Open-Label, Uncontrolled, Pilot Study
    Nozue, Tsuyoshi
    Michishita, Ichiro
    Mizuguchi, Ichiro
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2010, 71 (04): : 252 - 258
  • [45] Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
    Gupta, Bhanu
    Chee, Kok-Seng
    Neo, Li-Qi
    Tang, Charmaine
    Hariram, Jayaraman
    Tan, Geoffrey Chern-Yee
    Verma, Swapna
    Basu, Sutapa
    Appan, Deva-Priya
    Ting, Chan-Chun
    Abdin, Edimansyah
    Lee, Jimmy
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [46] Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1) (vol 10, pg 2579, 2022)
    Hoyte, F. C. L.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (04): : 1334 - 1334
  • [47] Effectiveness of a Digital Inhaler System for Patients With Asthma: A 12-Week, Open-Label, Randomized Study (CONNECT1) (vol 10, pg 2579, 2022)
    不详
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (01): : 1334 - 1334
  • [48] Selective serotonin reuptake inhibitor combined with dengzhanshengmai capsule improves the fatigue symptoms: a 12-week open-label pilot study
    Li, De-Qiang
    Li, Zhong-Chun
    Dai, Zhi-Yuan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (07): : 11811 - 11817
  • [49] Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study
    Dougados, Maxime
    Braun, Jurgen
    Szanto, Sandor
    Combe, Bernard
    Geher, Pal
    Leblanc, Veronique
    Logeart, Isabelle
    RHEUMATOLOGY, 2012, 51 (09) : 1687 - 1696
  • [50] EFFICACY AND SAFETY OF DIFFERENT SCHEMES OF ETORICOXIB ADMINISTRATION IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS - RESULTS OF A 12-WEEK, PROSPECTIVE, OPEN-LABEL STUDY
    Gaydukova, I.
    Rebrov, A.
    Nikitina, N.
    Nam, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 718 - 718
12345